HK1040400A1 - 具有抗腫瘤活性的嘧啶衍生物 - Google Patents

具有抗腫瘤活性的嘧啶衍生物

Info

Publication number: HK1040400A1
Authority: HK; Hong Kong
Prior art keywords: antitumor activity; pyrimidine derivatives; derivatives exhibiting; exhibiting antitumor; pyrimidine
Prior art date: 1998-07-16

Application number

HK02101842.6A

Other languages

English (en)

Inventor

上田和生

田中秀和

竹中秀行

Original Assignee

鹽野義製藥株式會社

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-16

Filing date

2002-03-11

Publication date

2002-06-07

2002-03-11 Application filed by 鹽野義製藥株式會社 filed Critical 鹽野義製藥株式會社

2002-06-07 Publication of HK1040400A1 publication Critical patent/HK1040400A1/zh

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

HK02101842.6A 1998-07-16 2002-03-11 具有抗腫瘤活性的嘧啶衍生物 HK1040400A1 (zh)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP20142398		1998-07-16
JP11032099		1999-04-19
PCT/JP1999/003863 WO2000004014A1 (fr)	1998-07-16	1999-07-16	Derives de pyrimidine manifestant une activite antitumorale

Publications (1)

Publication Number	Publication Date
HK1040400A1 true HK1040400A1 (zh)	2002-06-07

Family

ID=26449971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK02101842.6A HK1040400A1 (zh)	1998-07-16	2002-03-11	具有抗腫瘤活性的嘧啶衍生物

Country Status (10)

Country	Link
US (1)	US6420367B1 (zh)
EP (1)	EP1097933A4 (zh)
JP (1)	JP3910365B2 (zh)
KR (1)	KR20010071936A (zh)
CN (1)	CN1146561C (zh)
AU (1)	AU748816B2 (zh)
CA (1)	CA2336832A1 (zh)
HK (1)	HK1040400A1 (zh)
TW (1)	TW548275B (zh)
WO (1)	WO2000004014A1 (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6800630B2 (en)	2000-01-14	2004-10-05	Shionogi & Co., Ltd.	Pyrimidine derivatives having antitumor effect
WO2007022964A2 (de)	2005-08-24	2007-03-01	Abbott Gmbh & Co. Kg	Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
US8492378B2 (en) *	2006-08-03	2013-07-23	Takeda Pharmaceutical Company Limited	GSK-3β inhibitor
RU2011123647A (ru)	2008-11-10	2012-12-20	Вертекс Фармасьютикалз Инкорпорейтед	Соединения, полезные в качестве ингибиторов atr киназы
PT3354650T (pt)	2008-12-19	2022-06-20	Vertex Pharma	Compostos úteis como inibidores da cinase atr
EP2569289A1 (en)	2010-05-12	2013-03-20	Vertex Pharmaceuticals Incorporated	Pyrazines useful as inhibitors of atr kinase
MX2012013081A (es)	2010-05-12	2013-05-09	Vertex Pharma	Compuestos utiles como inhibidores de cinasa atr.
EP2569286B1 (en)	2010-05-12	2014-08-20	Vertex Pharmaceuticals Inc.	Compounds useful as inhibitors of atr kinase
JP2013526540A (ja)	2010-05-12	2013-06-24	バーテックスファーマシューティカルズインコーポレイテッド	Ａｔｒキナーゼ阻害剤として有用な化合物
EP2568984A1 (en)	2010-05-12	2013-03-20	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
CN102947272A (zh)	2010-05-12	2013-02-27	沃泰克斯药物股份有限公司	用作atr激酶抑制剂的2-氨基吡啶衍生物
US8623869B2 (en)	2010-06-23	2014-01-07	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of ATR kinase
MX2013011450A (es)	2011-04-05	2014-02-03	Vertex Pharma	Compuestos de aminopirazina utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr).
JP2014522818A (ja)	2011-06-22	2014-09-08	バーテックスファーマシューティカルズインコーポレイテッド	Ａｔｒキナーゼ阻害剤として有用な化合物
EP2723745A1 (en)	2011-06-22	2014-04-30	Vertex Pharmaceuticals Inc.	Compounds useful as inhibitors of atr kinase
WO2012178125A1 (en)	2011-06-22	2012-12-27	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
IN2014CN02501A (zh)	2011-09-30	2015-06-26	Vertex Pharma
CA2850566C (en)	2011-09-30	2022-05-03	Vertex Pharmaceuticals Incorporated	Process for making 4-[chloro-n-hydroxycarbonimidoyl]phenyl derivative
WO2013049719A1 (en)	2011-09-30	2013-04-04	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
MX2014003796A (es)	2011-09-30	2015-01-16	Vertex Pharma	Compuestos utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr).
US8853217B2 (en)	2011-09-30	2014-10-07	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of ATR kinase
US8841449B2 (en)	2011-11-09	2014-09-23	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of ATR kinase
WO2013071090A1 (en)	2011-11-09	2013-05-16	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
WO2013071094A1 (en)	2011-11-09	2013-05-16	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
EP2776420A1 (en)	2011-11-09	2014-09-17	Vertex Pharmaceuticals Incorporated	Pyrazine compounds useful as inhibitors of atr kinase
US8846917B2 (en)	2011-11-09	2014-09-30	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of ATR kinase
WO2013097052A1 (en)	2011-12-30	2013-07-04	Abbott Laboratories	Bromodomain inhibitors
JP2015515478A (ja)	2012-04-05	2015-05-28	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	Ａｔｒキナーゼの阻害剤として有用な化合物及びそれらの併用療法
EP2904406B1 (en)	2012-10-04	2018-03-21	Vertex Pharmaceuticals Incorporated	Method for measuring atr inhibition mediated increases in dna damage
EP2909202A1 (en)	2012-10-16	2015-08-26	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
PL3808749T3 (pl)	2012-12-07	2023-07-10	Vertex Pharmaceuticals Incorporated	Pirazolo[1,5-a]pirymidyny użyteczne jako inhibitory kinazy atr do leczenia chorób nowotworowych
WO2014143240A1 (en)	2013-03-15	2014-09-18	Vertex Pharmaceuticals Incorporated	Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
JP6543252B2 (ja)	2013-12-06	2019-07-10	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	ＡＴＲキナーゼ阻害剤として有用な２−アミノ−６−フルオロ−Ｎ−［５−フルオロ−ピリジン−３−イル］ピラゾロ［１，５−ａ］ピリミジン−３−カルボキサミド化合物、その調製、その異なる固体形態および放射性標識された誘導体
MX2016015874A (es)	2014-06-05	2017-03-27	Vertex Pharma	Derivados radiomarcadores de un compuesto de 2-amino-6-fluoro-n-[5 -fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida util como inhibidor de ataxia telangiectasia mutada y rad3 relacionado (atr) cinasa, preparacion de tal compuesto y diferentes formas solidas del mismo.
PT3157566T (pt)	2014-06-17	2019-07-11	Vertex Pharma	Método para tratamento de cancro utilizando uma combinação de inibidores chk1 e atr
CN104592217B (zh) *	2014-12-09	2018-03-13	沈阳药科大学	3‑(1,3,4‑噁二唑基)‑5‑苯氧基‑吡啶类衍生物及其制备方法与应用
CA3000684A1 (en)	2015-09-30	2017-04-06	Vertex Pharmaceuticals Incorporated	Method for treating cancer using a combination of dna damaging agents and atr inhibitors
PL3442972T3 (pl)	2016-04-15	2020-07-27	Abbvie Inc.	Inhibitory bromodomeny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6157587A (ja) *	1984-08-29	1986-03-24	Shionogi & Co Ltd	縮合複素環誘導体および抗潰瘍剤
DE69429078T2 (de) *	1993-10-01	2002-07-11	Novartis Ag	Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung

1999
- 1999-07-16 CN CNB998108057A patent/CN1146561C/zh not_active Expired - Fee Related
- 1999-07-16 CA CA002336832A patent/CA2336832A1/en not_active Abandoned
- 1999-07-16 WO PCT/JP1999/003863 patent/WO2000004014A1/ja not_active Application Discontinuation
- 1999-07-16 AU AU46540/99A patent/AU748816B2/en not_active Ceased
- 1999-07-16 US US09/743,721 patent/US6420367B1/en not_active Expired - Fee Related
- 1999-07-16 TW TW088112093A patent/TW548275B/zh not_active IP Right Cessation
- 1999-07-16 EP EP99929886A patent/EP1097933A4/en not_active Withdrawn
- 1999-07-16 KR KR1020017000686A patent/KR20010071936A/ko active IP Right Grant
- 1999-07-16 JP JP2000560120A patent/JP3910365B2/ja not_active Expired - Fee Related
2002
- 2002-03-11 HK HK02101842.6A patent/HK1040400A1/zh unknown

Also Published As

Publication number	Publication date
KR20010071936A (ko)	2001-07-31
WO2000004014A1 (fr)	2000-01-27
EP1097933A4 (en)	2001-11-07
CN1317003A (zh)	2001-10-10
CN1146561C (zh)	2004-04-21
CA2336832A1 (en)	2000-01-27
AU4654099A (en)	2000-02-07
EP1097933A1 (en)	2001-05-09
AU748816B2 (en)	2002-06-13
JP3910365B2 (ja)	2007-04-25
TW548275B (en)	2003-08-21
US6420367B1 (en)	2002-07-16

Publication	Publication Date	Title
HK1040400A1 (zh)	2002-06-07	具有抗腫瘤活性的嘧啶衍生物
IL137974A0 (en)	2001-10-31	Indole derivatives having antiviral activity
HK1035901A1 (en)	2001-12-14	Hiv inhibiting pyrimidine derivatives
EG23999A (en)	2008-03-19	Camptothecin derivatives having antitumor activity
AU5759999A (en)	2000-04-17	Pyrimidone derivatives
EP1040116A4 (en)	2001-10-31	FUNCTIONALIZED DERIVATIVES OF PYRIMIDINE
PL346117A1 (en)	2002-01-28	Antiviral indoleoxoacetyl piperazine derivatives
HK1042295A1 (zh)	2002-08-09	1h-咪唑並吡啶衍生物
HU9900120D0 (en)	1999-03-29	Benzosulfone derivatives
IL140284A0 (en)	2002-02-10	Adenosine derivatives
GB9910384D0 (en)	1999-07-07	Alpha-ketoamide derivatives
EP1033372A4 (en)	2000-10-04	COMPOSITIONS WITH ANTI-TUMOR ACTIVITY
EG23802A (en)	2007-08-22	2-Phenylpyran-4-one derivatives
GB9827729D0 (en)	1999-02-10	Thieno-indole derivatives
AU4103300A (en)	2000-09-28	Heterocyclic compounds having antitumor activity
GB0131034D0 (en)	2002-02-13	Benzocyclodecane derivatives with antitumor activity
EP1061912A4 (en)	2003-01-02	PHENANTHROFURANDERIVATE
AU1785599A (en)	1999-08-02	Novel pyrimidine derivatives
EP1124552A4 (en)	2005-01-05	CHRYSE DERIVATIVES AS ANTITUMULAR AGENTS
IL139276A0 (en)	2001-11-25	Cyclohexenondioxthio chromanoyl derivatives
HK1042478A1 (zh)	2002-08-16	2-氧代-2h-喹啉衍生物
EP0954316A4 (en)	2002-02-13	PYRIMIDINE DERIVATIVES
GB9912782D0 (en)	1999-08-04	Pyrimidine derivatives
SI1069894T1 (sl)	2005-12-31	Sestavine spisulosina, ki imajo protitumorsko aktivnost
AU9738298A (en)	1999-02-22	Pyrazolo-acridine derivatives having antitumour activity